These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20922869)

  • 1. [The AURORA study].
    Pietanza SC; Schena FP; Vassanelli C
    G Ital Cardiol (Rome); 2010 Jun; 11(6):449-52. PubMed ID: 20922869
    [No Abstract]   [Full Text] [Related]  

  • 2. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
    Duvernoy CS; Blumenthal R
    Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
    [No Abstract]   [Full Text] [Related]  

  • 3. [The CORONA study].
    Metra M; Zacá V; Nodari S; Cas LD; Maggioni AP
    G Ital Cardiol (Rome); 2008 Apr; 9(4):229-33. PubMed ID: 18543792
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
    Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
    Ridker PM;
    Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comment from the lipidologic viewpoint].
    Riesen WF
    Praxis (Bern 1994); 2009 Feb; 98(3):125-7. PubMed ID: 19180437
    [No Abstract]   [Full Text] [Related]  

  • 9. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 10. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosuvastatin in patients undergoing hemodialysis.
    Kassimatis TI; Konstantinopoulos PA
    N Engl J Med; 2009 Jul; 361(1):93; author reply 94-5. PubMed ID: 19579277
    [No Abstract]   [Full Text] [Related]  

  • 13. The JUPITER Trial: responding to the critics.
    Ridker PM; Glynn RJ
    Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosuvastatin and cardiovascular continuum when time is important.
    Barrios V; Escobar C
    J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 16. [The GISSI-HF trial].
    Tavazzi L; Nodari S
    G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.
    Cardiovasc J Afr; 2008; 19(2):117. PubMed ID: 18516361
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk in uremic patients: darkness after AURORA.
    Robles NR; Macias JF
    Ren Fail; 2010 Jan; 32(2):269-72. PubMed ID: 20199190
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosuvastatin in patients with elevated C-reactive protein.
    Jenny-Avital ER
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
    [No Abstract]   [Full Text] [Related]  

  • 20. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
    Albert MA; Glynn RJ; Fonseca FA; Lorenzatti AJ; Ferdinand KC; MacFadyen JG; Ridker PM
    Am Heart J; 2011 Jul; 162(1):106-14.e2. PubMed ID: 21742096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.